Navigation Links
Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
Date:5/21/2009

he BARDA contract, HGS achieved its first product sales by initiating the delivery of 20,000 doses of raxibacumab to the U.S. Strategic National Stockpile for emergency use in the treatment of inhalation anthrax. HGS recognized $153.8 million in raxibacumab revenue in the first quarter, including $127.8 million in product sales. The Company has now completed delivery and expects to recognize at least $8.0 million in additional raxibacumab revenue in the second quarter of 2009. The BLA is also being filed under the BARDA contract, and HGS will receive $10 million from the U.S. Government upon FDA licensure of raxibacumab.

About Anthrax

Anthrax infection is caused by a spore-forming bacterium, Bacillus anthracis, which multiplies in the body and produces lethal toxins. Most anthrax fatalities are caused by the irreversible effects of the anthrax toxins. Research has shown that the bacteria produce protective antigen, the key facilitator in the progression of anthrax infection at the cellular level. After protective antigen and the anthrax toxins are produced by the bacteria, protective antigen binds to the anthrax toxin receptor on cell surfaces and forms a protein-receptor complex that makes it possible for the anthrax toxins to enter the cells. Raxibacumab blocks the binding of protective antigen to cell surfaces and prevents the anthrax toxins from entering and killing the cells.

ABOUT HUMAN GENOME SCIENCES

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Albuferon has now
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Bevacizumab Market ... by Roche under the trade name of Avastin, bevacizumab ... In Feb.26, 2010, it was approved by CFDA to ... China all come from Roche ...
(Date:8/28/2015)... , Aug. 28, 2015  Today, in final recognition ... Contact Lens Health Week, 1-800 Contacts is sharing how ... that contact lens wearers who do not properly care ... for eye infections. Most contact lens ... but a clean lens case is sometimes overlooked.  When ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... ORANGE COUNTY, Calif., Feb. 15, 2011  Beckman Coulter, Inc. (NYSE: ... of directors unanimously recommends that Beckman Coulter,s stockholders tender ... ) at the previously announced price of $83.50 per ... (Logo:   http://photos.prnewswire.com/prnh/20031202/BECLOGO ) The transaction is ...
... Healthcare Solutions, Inc. (Allscripts) (Nasdaq: MDRX ) today ... 31, 2010. Fourth Quarter Highlights: ... legacy Allscripts bookings of $140.4 million and legacy Eclipsys bookings ... sequentially over the third quarter of 2010 Legacy ...
Cached Medicine Technology:Beckman Coulter's Board of Directors Recommends Stockholders Accept Danaher's Cash Tender Offer 2Beckman Coulter's Board of Directors Recommends Stockholders Accept Danaher's Cash Tender Offer 3Allscripts Reports Fourth Quarter Results 2Allscripts Reports Fourth Quarter Results 3Allscripts Reports Fourth Quarter Results 4Allscripts Reports Fourth Quarter Results 5Allscripts Reports Fourth Quarter Results 6Allscripts Reports Fourth Quarter Results 7Allscripts Reports Fourth Quarter Results 8Allscripts Reports Fourth Quarter Results 9Allscripts Reports Fourth Quarter Results 10Allscripts Reports Fourth Quarter Results 11Allscripts Reports Fourth Quarter Results 12Allscripts Reports Fourth Quarter Results 13Allscripts Reports Fourth Quarter Results 14Allscripts Reports Fourth Quarter Results 15
(Date:8/30/2015)... ... August 31, 2015 , ... ChopChop Kids, the nonprofit ... , recently elected two new officers to serve on the organization’s Board of ... inspiring and teaching kids to cook real food with their families and help ...
(Date:8/30/2015)... ... ... Lizzie’s Lice Pickers , a company that offers professional live removal ... lice head checks for just $10, which is a significant discount from the normal ... lice treatment products. “With kids returning to school, it is very important to be ...
(Date:8/30/2015)... Boca Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... and InHealth Media. Nutritional Products International and InHealth media is a global sales ... , “We are extremely pleased to continue our business relationship with Mr. Reid ...
(Date:8/29/2015)... ... , ... Rio Salado College President Chris Bustamante announced on Aug. ... Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for the last ... impact through innovative technologies and strategies. , “I am very proud to be able ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... two inventors from Miller Place, N.Y. "I specialize in manual therapy, and my ... addition, it can be used for additional muscle dysfunction throughout the body." , ...
Breaking Medicine News(10 mins):Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2
... bird flu virus has been detected in Asia, the British ... for any evidence of bird flu. ,The death ... and parks will be brought to the notice of the ... 1,200 sq Kms area will be brought under surveillance. ...
... AMA President, Dr Mukesh Haikerwal, today welcomed the Stern ... devastating health //impact of climate change on the world’s ... now. ,Commissioned by the UK Government and prepared ... the report has been described by British Prime Minister, ...
... the first online game in Kiswahili, with the aim of ... game is named as "What would you do?" (Ungefanyaje?) and ... importance of prevention and testing is understood. ,According ... not know how to protect themselves from Aids. ...
... medical treatment to correct the malady, a media report said ... problems affected 50 percent of men over 50 in China, ... said. ,But Andrew Yip Wai-chun, honorary consultant at ... Hospitals, who released details of the study, said just 36 ...
... in AIDS/HIV cases, and have begun to act fast to ... of gay citizens, The Chinese government has opened up the ... be administered jointly by the Disease Prevention and Control centre ... a response to the growing body of concern among HIV/AIDS ...
... death due to bird flu, according to the recent communiqué ... Abdel Rahman Shaheen said "It is the seventh death due ... domestic poultry, and was taken to hospital on October 4 ... in the line of fire, being in the path of ...
Cached Medicine News:Health News:A Timely Reminder Of Devastating Health Impact Of Climate Change 2
Intended for the quantitative determination of gammaglutamyl transferase activity in serum or plasma. Single vial, dry powder reagent. Readily soluble at room temperature. Reaction: Kinetic. Waveleng...
Intended for the quantitative determination of calcium in serum. Endpoint Reaction. Reaction complete within one minute, color developed is stable for 30 minutes. Wavelength: 570 nm. Linearity: 16 mg...
For the quantitative determination of alanine aminotransferase in serum used in routine examination and monitoring of therapy and relapses....
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
Medicine Products: